jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 26, 2019

July. 02, 2025

jRCTs021190007

Approach to elucidate the effect of ketamine on treatment resistant depression (AKD)

AKD (AKD)

Kudo Takashi

Hirosaki University Hospital

53 Honcho Hirosaki Aomori , Japan

+81-172335111

takf5@hirosaki-u.ac.jp

Kudo Takashi

Hirosaki University Hospital

53 Honcho Hirosaki Aomori , Japan

+81-172-33-5111

takf5@hirosaki-u.ac.jp

Recruiting

Aug. 01, 2019

Nov. 10, 2019
30

Interventional

single arm study

open(masking not used)

active control

single assignment

treatment purpose

patients with refractory depression diagnosed by psychiatrists

1. patients who has allergy to ketamine
2, patients who are diagnosed with glaucoma or high pressure of increased intracranial pressure

20age 0month 0week old over
65age 0month 0week old under

Both

refractory depression

1.iv both ketamine 0.5 mg/kg and midazolam 0.04 mg/kg for 40 min
2. taking a blood sample

depression

effect of ketamine on refractory depression

assessment of biomarkers after intravenous injection of ketamine

Hirosaki University General Certified Review Board
1 Bunkyocho, Hirosaki , Aomori

+81-172-39-5362

crb-hirosaki@hirosaki-u.ac.jp
Approval

July. 01, 2019

No

none

History of Changes

No Publication date
6 July. 02, 2025 (this page) Changes
5 Sept. 05, 2024 Detail Changes
4 April. 14, 2023 Detail Changes
3 Jan. 06, 2022 Detail Changes
2 July. 16, 2021 Detail Changes
1 July. 26, 2019 Detail